Advances in Focused Ultrasound for the Treatment of Brain Tumors

Tomography. 2023 May 29;9(3):1094-1109. doi: 10.3390/tomography9030090.

Abstract

Employing the full arsenal of therapeutics to treat brain tumors is limited by the relative impermeability of the blood-brain and blood-tumor barriers. In physiologic states, the blood-brain barrier serves a protective role by passively and actively excluding neurotoxic compounds; however, this functionality limits the penetrance of therapeutics into the tumor microenvironment. Focused ultrasound technology provides a method for overcoming the blood-brain and blood-tumor barriers through ultrasound frequency to transiently permeabilize or disrupt these barriers. Concomitant delivery of therapeutics has allowed for previously impermeable agents to reach the tumor microenvironment. This review details the advances in focused ultrasound in both preclinical models and clinical studies, with a focus on its safety profile. We then turn towards future directions in focused ultrasound-mediated therapies for brain tumors.

Keywords: blood–brain barrier; blood–tumor barrier; chemotherapy; glioma; immunotherapy; microbubble-enhanced focused ultrasound.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood-Brain Barrier / diagnostic imaging
  • Blood-Brain Barrier / pathology
  • Brain Neoplasms* / drug therapy
  • Brain Neoplasms* / therapy
  • Humans
  • Magnetic Resonance Imaging / methods
  • Tumor Microenvironment
  • Ultrasonography

Grants and funding

S.S. (Soma Sengupta) is supported by the Harold C. Schott Endowment, the Mischell Funds, and the Academic Research Collaborative Grant with CCHMC. K.J.H. and D.P.K. are supported by the University of Cincinnati Brain Tumor Center, Tech team. R.R. is supported by the Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship.